SEC Comment Letter 0000000000-23-005442 to Augmedix, Inc. (AUGX) (CIK 0001769804)
Augmedix, Inc. (AUGX) (CIK 0001769804)
Date: May 22, 2023 · CIK: 0001769804 · Accession: 0000000000-23-005442
AI Filing Summary & Sentiment
File numbers found in text: 333-272081
Letter
United States securities and exchange commission logo May 22, 2023 Paul Ginocchio Chief Financial Officer Augmedix, Inc. 111 Sutter Street, Suite 1300 San Francisco, California 94104 Re:Augmedix, Inc. Registration Statement on Form S-3 Filed May 19, 2023 File No. 333-272081 Dear Paul Ginocchio: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Rucha Pandit at (202) 551-6022 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services cc: John Rafferty
Show Raw Text
United States securities and exchange commission logo
May 22, 2023
Paul Ginocchio
Chief Financial Officer
Augmedix, Inc.
111 Sutter Street, Suite 1300
San Francisco, California 94104
Re:Augmedix, Inc.
Registration Statement on Form S-3
Filed May 19, 2023
File No. 333-272081
Dear Paul Ginocchio:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Rucha Pandit at (202) 551-6022 with any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services
cc: John Rafferty